Charles M. Richardson

1.4k total citations
22 papers, 766 citations indexed

About

Charles M. Richardson is a scholar working on Psychiatry and Mental health, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Charles M. Richardson has authored 22 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 3 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Charles M. Richardson's work include Schizophrenia research and treatment (13 papers), Bipolar Disorder and Treatment (6 papers) and Psychopathy, Forensic Psychiatry, Sexual Offending (2 papers). Charles M. Richardson is often cited by papers focused on Schizophrenia research and treatment (13 papers), Bipolar Disorder and Treatment (6 papers) and Psychopathy, Forensic Psychiatry, Sexual Offending (2 papers). Charles M. Richardson collaborates with scholars based in United States and Canada. Charles M. Richardson's co-authors include Deanna L. Kelly, Robert R. Conley, Daniel I. Sessler, Pekka Talke, Farzin Tayefeh, C.A. Tamminga, Irwin J. Kerber, Stephanie Feldman, Robert P. McMahon and Yang Yu and has published in prestigious journals such as Biological Psychiatry, Brain Research and Journal of Neurochemistry.

In The Last Decade

Charles M. Richardson

22 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles M. Richardson United States 15 321 136 116 113 109 22 766
Minna Oinas Finland 16 379 1.2× 314 2.3× 300 2.6× 82 0.7× 69 0.6× 25 1.1k
Katrin Druschky Germany 16 147 0.5× 70 0.5× 56 0.5× 137 1.2× 32 0.3× 41 737
Jeffrey Bierbrauer Germany 8 67 0.2× 348 2.6× 176 1.5× 84 0.7× 150 1.4× 12 780
Mirella Russo Italy 16 285 0.9× 41 0.3× 53 0.5× 70 0.6× 52 0.5× 60 761
Anna Maria Meaney Ireland 8 362 1.1× 48 0.4× 37 0.3× 31 0.3× 46 0.4× 11 656
Cindy C. Taylor United States 17 1.0k 3.2× 33 0.2× 231 2.0× 89 0.8× 55 0.5× 40 1.4k
Ana Sofia Costa Germany 18 365 1.1× 92 0.7× 119 1.0× 172 1.5× 155 1.4× 42 1.2k
Hiroshi Katagai Japan 13 138 0.4× 133 1.0× 33 0.3× 56 0.5× 27 0.2× 34 528
Katherine Grichnik United States 15 62 0.2× 69 0.5× 40 0.3× 129 1.1× 88 0.8× 38 961
Lynda Wells United States 16 65 0.2× 63 0.5× 24 0.2× 208 1.8× 85 0.8× 23 568

Countries citing papers authored by Charles M. Richardson

Since Specialization
Citations

This map shows the geographic impact of Charles M. Richardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles M. Richardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles M. Richardson more than expected).

Fields of papers citing papers by Charles M. Richardson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles M. Richardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles M. Richardson. The network helps show where Charles M. Richardson may publish in the future.

Co-authorship network of co-authors of Charles M. Richardson

This figure shows the co-authorship network connecting the top 25 collaborators of Charles M. Richardson. A scholar is included among the top collaborators of Charles M. Richardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles M. Richardson. Charles M. Richardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glassman, Matthew, Bethany A. DiPaula, Heidi J. Wehring, et al.. (2022). Anti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illness. Schizophrenia Research. 243. 163–169. 3 indexed citations
2.
Kelly, Deanna L., Matthew Glassman, Jae H. Park, et al.. (2020). O9.1. SATISFACTION WITH USING A NOVEL FINGERSTICK FOR ABSOLUTE NEUTROPHIL COUNT (ANC) AT THE POINT OF TREATMENT IN PATIENTS TREATED WITH CLOZAPINE. Schizophrenia Bulletin. 46(Supplement_1). S20–S21. 1 indexed citations
3.
Ponomareva, Olga, Heidi J. Wehring, Gopal Vyas, et al.. (2020). L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia. Schizophrenia Bulletin Open. 1(1). 1 indexed citations
4.
Wehring, Heidi J., Joseph P. McEvoy, Gopal Vyas, et al.. (2017). Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels. Psychiatric Quarterly. 89(1). 73–80. 16 indexed citations
5.
Vyas, Gopal, Ann Hackman, Charles M. Richardson, et al.. (2017). Clozapine in Reducing Aggression and Violence in Forensic Populations. Psychiatric Quarterly. 89(1). 157–168. 26 indexed citations
6.
Richardson, Charles M., et al.. (2016). Evaluation of the Safety of Clozapine Use in Patients With Benign Neutropenia. The Journal of Clinical Psychiatry. 77(11). e1454–e1459. 9 indexed citations
7.
Richardson, Charles M., et al.. (2015). The Risk of Suicide after Clozapine Discontinuation: Cause for Concern. Annals of Clinical Psychiatry. 27(4). 253–256. 22 indexed citations
8.
Kelly, Deanna L., Suzanne Hoi Shan Lo, Katherine Wright, et al.. (2010). Perception of Smoking Risks and Motivation to Quit Among Nontreatment-Seeking Smokers With and Without Schizophrenia. Schizophrenia Bulletin. 38(3). 543–551. 36 indexed citations
9.
Heishman, Stephen J., Katherine Wright, Heidi J. Wehring, et al.. (2010). Tobacco craving in smokers with and without schizophrenia. Schizophrenia Research. 127(1-3). 241–245. 25 indexed citations
10.
Harris, Andrew P., et al.. (2008). Validation of Arterial Oxygen Saturation Measurements in Utero Using Pulse Oximetry. American Journal of Perinatology. 10(3). 250–254. 5 indexed citations
11.
Kelly, Deanna L., Robert R. Conley, Stephanie Feldman, et al.. (2006). Adjunct Divalproex or Lithium to Clozapine in Treatment-Resistant Schizophrenia. Psychiatric Quarterly. 77(1). 81–95. 55 indexed citations
12.
Kelly, Deanna L., Charles M. Richardson, Yang Yu, & Robert R. Conley. (2006). Plasma concentrations of high‐dose olanzapine in a double‐blind crossover study. Human Psychopharmacology Clinical and Experimental. 21(6). 393–398. 32 indexed citations
13.
Conley, Robert R., Deanna L. Kelly, Charles M. Richardson, et al.. (2005). Risperidone, Quetiapine, and Fluphenazine in the Treatment of Patients With Therapy-Refractory Schizophrenia. Clinical Neuropharmacology. 28(4). 163–168. 48 indexed citations
14.
Conley, Robert R., Deanna L. Kelly, Lori L. Beason‐Held, Henry H. Holcomb, & Charles M. Richardson. (2004). The Effects of Clozapine and High-Dose Olanzapine on Brainfunction in Treatment-Resistantschizophrenia: A Case Study. Journal of Psychopharmacology. 18(3). 429–431. 3 indexed citations
15.
Kelly, Deanna L., et al.. (2003). Adverse Effects and Laboratory Parameters of High-Dose Olanzapine vs. Clozapine in Treatment-Resistant Schizophrenia. Annals of Clinical Psychiatry. 15(3/4). 181–186. 41 indexed citations
16.
Conley, Robert R., C.A. Tamminga, Deanna L. Kelly, & Charles M. Richardson. (1999). Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biological Psychiatry. 46(1). 73–77. 100 indexed citations
17.
18.
Conley, R., et al.. (1994). Clozapine response varies in deficit vs non-deficit schizophrenic subjects. Biological Psychiatry. 35(9). 746–746. 20 indexed citations
19.
Richardson, Charles M.. (1981). Learning Disability Procedures: A Human Rights Perspective. Journal of Learning Disabilities. 14(1). 7–8. 1 indexed citations
20.
Kerber, Irwin J., et al.. (1968). Pregnancy in a patient with a prosthetic mitral valve. Associated with a fetal anomaly attributed to warfarin sodium.. PubMed. 203(3). 223–5. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minna Oinas Breakdown of academic impact, for papers by Katrin Druschky Breakdown of academic impact, for papers by Jeffrey Bierbrauer Breakdown of academic impact, for papers by Mirella Russo Breakdown of academic impact, for papers by Anna Maria Meaney Breakdown of academic impact, for papers by Cindy C. Taylor Breakdown of academic impact, for papers by Ana Sofia Costa Breakdown of academic impact, for papers by Hiroshi Katagai Breakdown of academic impact, for papers by Katherine Grichnik Breakdown of academic impact, for papers by Lynda Wells
Rankless by CCL
2026